Name | Rapamycin |
---|---|
Supplier | Tocris Bioscience |
Catalog | 3118 |
Prices | $259.00 |
Sizes | 1 mg |
Cas Number | 53123-88-9 |
Chemical Name | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone |
Formula | C51H79NO13 |
Molecular Weight | 914.18 |
Purity | >98 % |
Description | Antifungal and immunosuppressant. Specific inhibitor of mTOR (mammalian target of Rapamycin). Complexes with FKBP-12 and binds mTOR inhibiting its activity. Inhibits interleukin-2-induced phosphorylation and activation of p70 S6 kinase. Induces autophagy in yeast and mammalian cell lines. Drives hPSC differentiation to mesendoderm and blood progenitor cells. Also used as a chemical dimerizer; rapamycin and GA 3 -AM (Cat. No. 5407) chemically inducible dimerization systems are orthogonal. |
Supplier Page | Shop |
Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR. Nature. 1992 Jul 2;358(6381):70-3.
Huang S, Bjornsti MA, Houghton PJ. Cancer Biol Ther. 2003 May-Jun;2(3):222-32.
Kobayashi S, Kishimoto T, Kamata S, Otsuka M, Miyazaki M, Ishikura H. Cancer Sci. 2007 May;98(5):726-33.
Fleming A, Noda T, Yoshimori T, Rubinsztein DC. Nat Chem Biol. 2011 Jan;7(1):9-17.